Shriram Bioseed, a DCM Shriram Ltd group company and US-based AgBiotech company Key Gene today announced a multi-year strategic co-development research programme.
The programme will be for the development of improved rice hybrids with higher yields, increased tolerance to abiotic stresses, and better grain quality for consumers in India and Southeast Asia.
According to a press release issued by city-based seed developer, Key Gene's innovation platforms will be exploited to boost these important traits in Bioseed's elite rice germplasm and the program will lead to growth of hybrid rice markets in the region.
Under this partnership both companies will make joint investments, it said.
"The aim of this strategic investment is to generate value in rice by incorporating new traits that help vigorous growth of rice with customised preferences for consumers in different parts of India and in the South-East Asian rice market.
The end goal is to benefit the rice farmers by providing them with seed of high performing hybrids," Arjen van Tunen, CEO of KeyGene said.
"We are excited about our extended collaboration with KeyGene and the opportunity of using KeyGene's proprietary technologies and innovation platforms to develop novel tools specifically for rice which will enable us to improve our products with increased precision and efficiency," Director Research at Shriram Bioseed, Paresh Verma said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
